These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 26856188)
1. Tc-99m Glu-Cys-Gly-His-Gly-Lys (ECG-HGK), a novel Tc-99m labeled hexapeptide for molecular tumor imaging. Kim DW; Kim MH; Kim CG J Labelled Comp Radiopharm; 2016 Mar; 59(3):124-8. PubMed ID: 26856188 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model. Kim DW; Kim WH; Kim MH; Kim CG Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents. Kim DW; Kim WH; Kim MH; Kim CG J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of Tc-99m and fluorescence-labeled elastin-derived peptide, VAPG for multimodal tumor imaging in murine tumor model. Kim MH; Kim CG; Kim SG; Kim DW J Labelled Comp Radiopharm; 2017 Dec; 60(14):649-658. PubMed ID: 29023950 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals. Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852 [TBL] [Abstract][Full Text] [Related]
6. A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery. Kim MH; Kim SG; Kim DW Ann Nucl Med; 2019 Aug; 33(8):606-616. PubMed ID: 31134434 [TBL] [Abstract][Full Text] [Related]
7. Novel Tc-99m labeled ELR-containing 6-mer peptides for tumor imaging in epidermoid carcinoma xenografts model: a pilot study. Kim DW; Kim WH; Kim MH; Kim CG Ann Nucl Med; 2013 Dec; 27(10):892-7. PubMed ID: 23990397 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting. Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818 [TBL] [Abstract][Full Text] [Related]
9. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer. Liu S; Hsieh WY; Kim YS; Mohammed SI Bioconjug Chem; 2005; 16(6):1580-8. PubMed ID: 16287258 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical. Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386 [TBL] [Abstract][Full Text] [Related]
11. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
12. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Tran T; Engfeldt T; Orlova A; Sandström M; Feldwisch J; Abrahmsén L; Wennborg A; Tolmachev V; Karlström AE Bioconjug Chem; 2007; 18(6):1956-64. PubMed ID: 17944527 [TBL] [Abstract][Full Text] [Related]
13. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy. Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743 [TBL] [Abstract][Full Text] [Related]
14. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging. Lu X; Zhao L; Xue T; Zhang H J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042 [TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores. Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging. Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758 [TBL] [Abstract][Full Text] [Related]
17. A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors. Kim MH; Kim SG; Kim DW PLoS One; 2022; 17(2):e0263474. PubMed ID: 35120180 [TBL] [Abstract][Full Text] [Related]
19. A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model. Kim MH; Kim SG; Kim DW J Labelled Comp Radiopharm; 2018 Jun; 61(7):557-566. PubMed ID: 29603784 [TBL] [Abstract][Full Text] [Related]
20. Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts. Xie WH; Zhang B; Wang LH; Liu CY; Chang C; Lei B; Wu YW Cancer Biother Radiopharm; 2015 Apr; 30(3):117-24. PubMed ID: 25714734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]